MR contrast agents, the old and the new.

scientific article published on 26 September 2006

MR contrast agents, the old and the new. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EJRAD.2006.06.021
P698PubMed publication ID17005349

P2093author name stringMarie-France Bellin
P433issue3
P921main subjectcontrast agentQ6849688
P304page(s)314-323
P577publication date2006-09-26
P1433published inEuropean Journal of RadiologyQ15759696
P1476titleMR contrast agents, the old and the new.
P478volume60

Reverse relations

cites work (P2860)
Q36625800(89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer
Q36747329A choline derivate-modified nanoprobe for glioma diagnosis using MRI.
Q48920812A novel ascorbic acid-resistant nitroxide in fat emulsion is an efficient brain imaging probe for in vivo EPR imaging of mouse.
Q47759079A tailored nanosheet decorated with a metallized dendrimer for angiography and magnetic resonance imaging-guided combined chemotherapy
Q36028884A transferrin-target magnetic/fluorescent dual-mode probe significantly enhances the diagnosis of non-small cell lung cancer.
Q36836266Abdominal MRI advances in the detection of liver tumours and characterisation
Q38639877Advanced Functional Nanomaterials for Theranostics
Q96773356Anthropogenic gadolinium in freshwater and drinking water systems
Q36478976Application of atomic force microscopy in morphological observation of antisense probe labeled with magnetism
Q42026547Augmenting regional and targeted delivery in the pulmonary acinus using magnetic particles
Q38000520Biological applications of magnetic nanoparticles.
Q28307243Classification and basic properties of contrast agents for magnetic resonance imaging
Q37832178Clinical applications of gadobenate dimeglumine-enhanced magnetic resonance cholangiography: an expanded pictorial review.
Q38979886Clinically Approved Nanoparticle Imaging Agents
Q37503563Combining hyperpolarized 13 C MRI with a liver-specific gadolinium contrast agent for selective assessment of hepatocyte metabolism
Q26768472Contrast Enhanced MRI in the Diagnosis of HCC
Q28235682Design of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkers
Q34214594Development of EGFR-targeted nanoemulsion for imaging and novel platinum therapy of ovarian cancer
Q39107521Different cell responses induced by exposure to maghemite nanoparticles
Q34379033Effect of MR contrast agents on quantitative accuracy of PET in combined whole-body PET/MR imaging
Q34242694Elemental imaging of MRI contrast agents: benchmarking of LA-ICP-MS to MRI.
Q38155457Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening
Q52883948Gadobutrol in the central nervous system at three doses: results from a phase II, randomized, multicenter trial.
Q41879002Gadolinium compounds signaling through TLR4 and TLR7 in normal human macrophages: establishment of a proinflammatory phenotype and implications for the pathogenesis of nephrogenic systemic fibrosis
Q41391342Gadolinium in pediatric cardiovascular magnetic resonance: what we know and how we practice
Q33822955Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent
Q33839558Gd(III) functionalized gold nanorods for multimodal imaging applications
Q53072973Half-dose gadobenate dimeglumine versus standard-dose gadodiamide in dynamic magnetic resonance imaging of non-cirrhotic livers: a retrospective intra-individual crossover comparison.
Q36292525Heterogeneous dimer peptide-conjugated polylysine dendrimer-Fe3O4 composite as a novel nanoscale molecular probe for early diagnosis and therapy in hepatocellular carcinoma
Q40744914Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging
Q42181384Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.
Q24654739Imaging of liver cancer
Q37250096Immediate Adverse Reactions to Gadolinium-Based MR Contrast Media: A Retrospective Analysis on 10,608 Examinations
Q37678720Improved quantification of myocardial blood flow using highly constrained back projection reconstruction
Q55467668In Vivo Molecular Characterization of Abdominal Aortic Aneurysms Using Fibrin-Specific Magnetic Resonance Imaging.
Q37069946Introductory Chemistry: A Molar Relaxivity Experiment in the High School Classroom
Q57185167MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosis
Q33847006Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics
Q30841850Manganese doped fluorescent paramagnetic nanocrystals for dual-modal imaging.
Q57258860Mesoporous silica-coated luminescent Eu3+doped GdVO4nanoparticles for multimodal imaging and drug delivery
Q50527499Monitoring bone marrow-originated mesenchymal stem cell traffic to myocardial infarction sites using magnetic resonance imaging.
Q26740054Multiwalled carbon nanotube hybrids as MRI contrast agents
Q37140824Nephrogenic systemic fibrosis: an emerging entity
Q33574781Nuclear microscopy: a novel technique for quantitative imaging of gadolinium distribution within tissue sections
Q33852473Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications
Q37755998Paramagnetic liposome nanoparticles for cellular and tumour imaging.
Q58205745Pilot Study of Inhaled Aerosols Targeted via Magnetic Alignment of High Aspect Ratio Particles in Rabbits
Q64252823Preparation and Properties of Tumor-Targeting MRI Contrast Agent Based on Linear Polylysine Derivatives
Q81758644Prospects for lanthanides in structural biology by NMR
Q40575295RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin
Q30436623Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice.
Q55227929Recent advances in non-invasive magnetic resonance imaging assessment of hepatocellular carcinoma.
Q48107343Relative diffusion of paramagnetic metal complexes of MRI contrast agents in an isotropic hydrogel medium.
Q58993973Renal Transplantation Is Associated with Improved Clinical Outcomes in Nephrogenic Systemic Fibrosis
Q33415333Responsive MRI agents for sensing metabolism in vivo
Q35390321Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study
Q36517070Strategies for Target-Specific Contrast Agents for Magnetic Resonance Imaging
Q46722275Studies on the redox activity of iron N,O-complexes: Potential T1-contrast agents.
Q57181647T-T molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents
Q42876782Targeted Molecular Imaging of Antigen OC183B2 in Ovarian Cancers Using MR Molecular Probes
Q31169933Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement

Search more.